Stroke Trial, Recruiting NCT06700005 Sponsor: Georgetown University Condition: Stroke
Back to Stroke

Stroke Trial, Recruiting

NCT06700005
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Stroke survivors:

  • Adults aged 18 or older who have had a brain injury caused by a stroke
  • People who learned English at age 8 or younger

Control group (people without stroke):

  • Adults aged 18 or older
  • People who learned English at age 8 or younger

Who may not be able to join:

  • People with a history of another brain condition (such as multiple sclerosis, dementia, or a head injury that caused loss of consciousness) that could affect how results are interpreted
  • People with a severe psychiatric condition that would interfere with taking part in the study
  • People with a diagnosed learning disorder
  • People with hearing or vision loss that affects their ability to complete the study tasks, even when using glasses or hearing aids
  • People who are unable to follow the study procedures, even with extra support
  • People whose MRI scans cannot be done because they have metal in their body that is not safe for MRI machines
  • People who are pregnant
  • People who experience claustrophobia (fear of enclosed spaces), which could prevent them from having an MRI scan

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 14 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Peter Turkeltaub, MD,PhD, Georgetown University; MedStar National Rehabilitation Hospital

Phone: 202-687-5205

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Georgetown University
Registry
ClinicalTrials.gov
Start date
12 January 2023
Est. completion
31 August 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

MP-RAGE (Magnetization Prepared Rapid Acquisition Gradient Echo); DTI (Diffusion Tensor Imaging); Behavioral testing

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov